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BACKGROUND:
Our lab is interested in Parkinson’s Disease. One 
hallmark of PD is the accumulation of toxic protein 
aggregates made up of alpha-synuclein known as Lewy 
Bodies. It is believed that these protein aggregates are 
cleared from the cell via autophagy, a cellular process in 
which proteins, organelles, other cellular debris are 
engulfed in a vesicle (autophagosome) and degraded 
following fusion with a lysosome (Morrison). Despite 
many advances being made in the study of autophagy 
and PD, The PD community has yet to find any disease 
modifying treatments. With this in mind, we have 
decided to shift our focus towards lipid signaling, a 
topic that has not yet been adequately addressed. We 
recently performed an unbiased lipidomic screen of 
factors that affect autophagy and identified Stearic 
Acid, Hydroxystearic acid, and 5-OXO-ETE as autophagy 
inhibitors. After validation of these lipids, we set out to 
test the ability of an autophagy inducing drug, Torin 1 
to rescue the autophagy inhibition associated with 
treatment of these lipids.
METHODS:
Cell culture
• Treat SH-SY5Y cells with Retinoic acid for  7 days.
• Treat cells with 2 different doses of fresh Torin 1 
(250nM or 1 uM) or HBSS (positive control) with 
and without Bafilomycin A1 in media prepared 
with freshly thawed 15% FBS for 4 hours.
• Lyse and sonicate cells and then perform western 
blot.
Western blot
• Run samples on a 16% Tris glycine gel for 90 
minutes at 130 volts.
• Transfer samples via iBlot2 machine for 20 
minutes at 10 volts.
• Membrane was probed for LC3-II and B-actin.
Torin 1 Restores Autophagy
Through Lipid-Screening Inhibition
RESULTS:
• Our initial hypothesis was unsuccessful 
because it did not yield reliable results, so we 
believe that the dose may either not have 
been appropriate or the solution was too old 
to use.
• Our second attempt was much more reliable 
and successful as we can see in lane 6, it looks 
thicker than lane 2. This can be seen by the 
strength/intensity and darkness of the band 
(6). This means that Torin at 1uM worked.
DISCUSSION AND FUTURE DIRECTIONS:
• This is still  a work in progress. We will 
conduct our Torin rescue experiment next.
• With our next Torin experiment, we expect
that when we treat with lipids, we will see a
decrease in autophagy compared to ethanol
control. When we treat with lipids and Torin,
we should see autophagy go back to normal
or close to the control.
• We seemed to have successfully identified the 
problem with our initial experiment. We will 
repeat the planned experiment with a dosage 
of 1uM (see below)
• Due to extenuating circumstances, our 
research program has been postponed and 
we’ll perform the above experiment as soon 
as we are able to.
• Our results will add to our understanding of
the molecular mechanism of action for these 
3 autophagy-repressing lipids which could 
ultimately aid in the development of 
treatments for neurodegenerative diseases.
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